Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)

DMDR, a daunorubicin derivative with a higher therapeutic index and lower cardiotoxicity than either the parent drug or doxorubicin, is active when given PO in experimental animals. We studied its pharmacokinetics in ten patients receiving DMDR IV or PO or IV and PO sequentially at 10-12.5 mg/m2. DMDR and its metabolites were quantified by high-performance liquid chromatography and fluorometry. In nine patients who received DMDR IV the unchanged drug disappeared from the plasma biphasically with a mean terminal half-life of 27.0 +/- 5.5 h, an apparent volume of distribution of 63.9 +/- 12.61 kg-1, and a total clearance of 1.9 +/- 0.41 kg-1 h-1. In 24 h only 5.1% +/- 1.1% of the dose was excreted in the urine. In comparison, in 19 studies the plasma half-life of DMDR given PO was 34.8 +/- 6.7 h, 2.3% +/- 1.3% was excreted in the urine in 24 h, and the maximum plasma drug concentration was reached in about 1 h. The bioavailability of DMDR given PO was about 39% according to comparison of the areas under the plasma DMDR concentration versus time curves for the two routes, but 45% according to comparison of the 24-h cumulative urinary excretion rates. In one patient with severe liver dysfunction following oral administration, the plasma DMDR half-life was 56.8 h, more than twice the average length. By either route, the drug was quickly metabolized to one major metabolite, DMDR-ol. The plasma half-life of DMDR-ol was 72.5 +/- 24.7 h, or 35.7 +/- 7.4 when DMDR was administered IV or PO. In the plasma, DMDR-ol always exceeded DMDR in concentration. Moreover, the 24 h cumulative urinary excretion of DMDR-ol as a percentage of the dose of DMDR administered was 7.8 following IV and 7.4 following PO administration.

Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione

The clinical kinetics of 1, 4-dihydroxy-5,8-bis[[ 2-[(2-hydroxyethyl) amino] ethyl] amino]-9,10-anthracenedione dihydrochloride (DHAQ) are reported. DHAQ, 1 to 3 mg/m2, was administered as an intravenous bolus to six patients with metastatic cancer. Plasma clearance of the drug followed a biphasic pattern with a harmonic mean initial half-life (t 1/2) of 13.7 min and a terminal t 1/2 of 37.4 hr. Recovery of unchanged drug in the urine was 6.8% at 24 hr and 7.3% at 72 hr, while the corresponding recovery of total radioactivity was 9.4% and 11.3%. Apparent volume of distribution of DHAQ was about 13.8 +/- 2.9 l/kg. Total clearance was 238.7 ml/kg/hr, twice the creatinine clearance.

Sequences of early and late phases of repolarization on dog ventricular epicardium

Monophasic action potentials from 32 to 43 epicardial sites were recorded with concentric suction electrodes in 11 dogs during atrial pacing at a constant rate. The duration of action potentials and the sequence of repolarization referenced to the onset of ventricular activation at 50% of the highest plateau amplitude and the end of the action potential were determined. These quantities were correlated with activation sequence determined from action potential upstrokes. On the anterior ventricular surface, both 50% and 100% repolarization sequences were qualitatively similar to activation sequence and showed positive correlation coefficients. On the posterior ventricular surface, 50% and 100% repolarization sequences had little qualitative resemblance to activation sequence and showed lower correlation coefficients. Correlations between the patterns of 100% repolarization and action potential duration were significantly higher on the posterior than the anterior ventricular surface. These findings demonstrate that activation sequence has less influence on repolarization sequence on the posterior than the anterior wall and that action potential duration is the major determinant of repolarization sequence on the posterior wall. These findings extend previous descriptions of the normal sequence of ventricular repolarization and the relative roles of activation and action potential duration in determining that sequence. The study also showed differences between the sequences of 50% and 100% repolarization suggesting different slopes of action potential downstrokes at various ventricular sites with steeper slopes at the posterior basal and upper anterolateral left ventricular wall. This finding adds new detail to previous descriptions of the distribution of intrinsic ventricular recovery properties.

Use of a computer in the calibration of dye dilution curves by a dynamic method

Images